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Introduction
Over the past decades, the outcomes in patients with ST-ele-
vation myocardial infarction (STEMI) have improved [1]. 
However, putting aside good early results, late outcomes 
are still not satisfactory, especially in patients with non-ST-
elevation acute coronary syndromes in whom late progno-
sis is worse than in STEMI patients. Thus, searching for 
predictors of long-term mortality is still justified. Location 
of infarction is established as one such predictor. Inferior 
wall STEMI is thought to have a better long-term prognosis 
than anterior STEMI [2]. However, inferior STEMI may be 
the result of either circumflex artery (Cx) or right coronary 
artery (RCA) disease, leading to different outcomes. Never-
theless, significant narrowing of the Cx frequently does not 
present with ischemic signs on the ECG, even if the artery is 
occluded. Such a phenomenon can lead to the wrong quali-
fication and delayed angiography during STEMI or stable 
coronary artery disease [3]. Hence, inadequate treatment of 
the narrowing of this artery can lead to worse outcomes. The 
number of arteries affected by atherosclerosis is an addi-
tional factor influencing the outcome. Moreover, prognosis 
may be affected by coronary artery dominance. It has been 
reported that left coronary artery dominance in the case of 
significant coronary artery disease is related to worse prog-
nosis [4]. Moreover, the issue whether Cx or RCA disease 
is worse, still remains unclear. Additionally, different out-
comes related to Cx or RCA stenosis in patients with ante-
rior STEMI treated invasively have not been confirmed. 
Accordingly, the aim of this analysis was to establish if 
narrowing of the Cx is related to diverse outcomes in com-
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Background Occlusion of the circumflex artery (Cx) often 
does not present signs in the ECG. It can lead to delayed 
angiography during ST-elevation myocardial infarction 
(STEMI). The aim of this analysis was to determine if Cx 
narrowing is related to diverse outcomes in comparison 
with right coronary artery (RCA) stenosis in patients with 
STEMI, treated with percutaneous coronary intervention 
(PCI) of the left descending artery (LAD).
Methods and results Inclusion criteria were as follows: first 
STEMI treated with PCI of the LAD and additional signifi-
cant (≥ 70 %) Cx or RCA narrowing—two-vessel disease. 
A total of 234 consecutive patients with STEMI were in-
cluded. Total mortality was estimated during long-term 
follow-up, at mean 639 (± 224) days after STEMI. Patients 
with Cx narrowing constituted 46 % (N = 108) of the study 
population, and patients with RCA narrowing amounted to 
54 % (N = 126). Patients with narrowing of the Cx had worse 
long-term outcomes in terms of mortality than patients with 
RCA narrowing (22 vs. 11 %, p < 0.05, respectively). Mul-
tiple regression analysis showed independent risk factors 
for death during long-term follow-up such as: age, ejection 
fraction and Cx narrowing.
Conclusion Significant Cx narrowing leads to worse out-
comes than RCA narrowing in patients with STEMI treated 
with PCI of the LAD.
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parison with the narrowing of RCA in patients with STEMI 
treated with percutaneous coronary intervention (PCI) of 
the left anterior descending artery (LAD).
Methods
The study was conducted among consecutive STEMI 
patients who underwent PCI of the LAD in our centre 
between 2005 and 2011. The study was based upon ret-
rospective analysis of a clinical registry conducted in the 
authors’ own department. Inclusion criteria were as follows: 
first STEMI treated with PCI of LAD and additional, visu-
ally estimated, significant (≥ 70 %) narrowing of the Cx (seg-
ments 11–13) or RCA (segments 1–3)—two-vessel disease. 
Patients with ostial Cx stenosis or total occlusions of the Cx 
or RCA were excluded. Inclusion criteria were met by 234 
patients who constituted a homogenous group. Every signif-
icant narrowing was treated invasively with planned, staged 
PCI. Staged PCI was performed within the first month after 
STEMI in patients with persisting clinical symptoms and/or 
a large vascularisation area of the narrowed vessel, accord-
ing to the regimen prevailing in the centre. Patients with 
unsuccessful planned PCI were excluded from the analysis. 
Pharmacotherapy was administered according to the Euro-
pean Society of Cardiology guidelines binding at that time. 
All patients received a loading dose of clopidogrel (600 mg) 
and aspirin (300 mg). There were no differences concerning 
other pharmacological agents between the compared groups 
of patients. Mean follow-up was 639 (± 224) days. Total 
mortality was estimated at follow-up. Informed consent was 
obtained from each patient.
Follow-up
Follow-up consisted of three stages. The first stage was 
a questionnaire sent to patients 2 years after myocardial 
infarction. The next stage, if the patient did not send the 
questionnaire back, was telephone contact with the patient 
or with his family. Missing data were collected from the 
Provincial Administration Office. Information concerning 
endpoint was obtained in 100 % of the cases. The office 
provides information concerning death of a person; how-
ever, the cause of death remains unknown. The study was 
approved by the local Bioethics Committee.
Statistical analysis
Distribution of variables was assessed with the Kol-
mogorov–Smirnov test followed by the Student’s t-test, 
ANOVA test, or Mann–Whitney test for comparative analy-
sis, the choice of a test depended on the distribution of a 
variable. The interdependences between constant variables 
were calculated with the Spearman or Pearson test depend-
ing on the statistical distribution. Correlations between 
dichotomous variables were analysed with the chi-square 
test. Multivariable analysis was performed with logistic 
regression testing. A P value < 0.05 was considered statisti-
cally significant. The results are presented as mean values 
with standard deviation or as percentage values presenting 
relative frequency. Statistical analysis was performed with 
Statistica 10.0 program (StatSoft, Inc. Tulsa, USA).
Results
The study population was composed of 46 % (N = 108) of 
patients with Cx narrowing and 54 % (N = 126) with RCA 
narrowing. The Cx and RCA groups did not differ according 
to baseline clinical data (Table 1). There were no signifi-
cant differences concerning either biochemical or history 
data (Table 2). Pharmacological treatment possibly affect-














Age (years) 64.92 9.92 66.30 12.44 ns
Male gender 91 72 % 74 69 % ns
Body mass index (kg/m2) 28.10 5.45 26.65 3.09 ns
Systolic blood pressure 
on admission (mmHg)
153.71 145.54 146.60 36.11 ns
Diastolic blood pressure 
on admission (mmHg)
85.81 14.09 90.12 17.50 ns
Heart rate on admission 
(beats/minute)
75.23 16.27 78.80 16.86 ns
Ejection fraction of left 
ventricle (%)
40 10.44 42 10.32 ns
Mean Killip class on 
admission
1.42 0.51 1.46 0.54 ns
Time pain to door 
(minutes)
267.45 187.23 248.49 174.12 ns
Mean number of im-
planted stents
1.27 0.70 1.21 0.51 ns
POBA during index 
procedure
3 2 % 3 3 % ns
% of implanted DES dur-
ing index procedure
40 32 % 36 34 % ns
POBA during second 
stage of PCI
0 0 % 1 1 % ns
% of implanted DES dur-
ing second stage of PCI
41 33 % 39 36 % ns
PCI of proximal LAD 
during index procedure
52 41 % 42 39 % ns
RCA dominance 82 65 % 72 67 % ns
RCA right coronary artery, Cx circumflex artery, ns not significant, 
LAD left descending artery, DES drug-eluting stent, POBA plain old 
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sion analysis showed that independent risk factors for death 
during the follow-up were: age, ejection fraction and Cx 
narrowing (Table 4).
Discussion
The long-term prognosis in patients with STEMI still 
requires improvement in the future. Different scales and 
factors predicting hospital and late outcomes have already 
been created [5–8]. Most of the scales used in mortality 
prediction lack angiographic and procedural aspects [9, 
10]. One of the factors influencing the long-term efficacy 
of percutaneous interventions is the type of stent used for 
the procedure. Despite previous apprehension concerning 
drug-eluting stents (DES), they have turned out to be safe 
and efficient, also in the treatment of patients with acute 
coronary syndromes [11]. DES have significantly limited 
restenosis, which potentially may improve the prognosis of 
patients; however, data concerning the influence of reste-
ing the outcome (beta-blockers, ACE inhibitors and statins) 
was also comparable at discharge. Long-term mortality 
was estimated at a level of 16 %. Mortality was higher in 
patients with Cx than with RCA narrowing (22 (N = 23) vs. 
11 % (N = 14) respectively, p = 0.031, (Fig. 1). The ejection 
fraction of the left ventricle, age, glycaemia on admission, 
significant Cx stenosis and creatine kinase-myocardial band 
on admission were found to be risk factors for long-term 
mortality in univariate analysis (Table 3). Multiple regres-
Fig. 1 Kaplan–Meier curves displaying cumulative proportion surviv-
als during long-term follow-up according to circumflex or right coro-
nary artery narrowing (p < 0.05)
 














Creatinine on admission 
(mg/dl)
1.01 0.22 1.06 0.19 ns
Total cholesterol on 
admission (mg%)
178.87 54.17 193.64 44.13 ns
HDL cholesterol on 
admission (mg%)
44.06 14.91 47.66 10.09 ns
LDL cholesterol on ad-
mission (mg%)
110.00 40.43 114.79 45.83 ns
Triglycerides on admis-
sion (mg%)
116.92 60.65 127.32 58.16 ns
Glucose level on admis-
sion (mg%)
119.38 33.72 115.50 43.92 ns
CKMB on admission (IU) 73.39 79.93 103.48 138.16 ns
Maximal CKMB (IU) 250.68 245.34 253.35 331.97 ns
Hypercholesterolaemia 59 47 % 54 50 % ns
History of diabetes 
mellitus
25 20 % 20 19 % ns
History of hypertension 73 58 % 62 57 % ns
RCA right coronary artery, Cx circumflex artery, ns not significant, 
HDL high-density lipoprotein cholesterol, LDL low-density 
lipoprotein cholesterol, CKMB creatine kinase-myocardial band, SD 
standard deviation













Ejection fraction of left 
ventricle (%)
42.88 9,37 26.55 6.97 < 0.001
Age (years) 64.14 10.60 72.80 8.24 < 0.001
Glucose level on ad-
mission (mg %)
112.89 29.68 150.25 61.52 0.005
Significant Cx stenosis 84 43 % 23 63 % 0.021
CKMB on admission 78.83 83.66 130.62 160.88 0.013
Cx circumflex artery, CKMB creatine kinase-myocardial band, SD 
standard deviation




B SE of 
B
t(66) p
Age (years) 0.2782 0.1024 0.0098 0.0036 2.7165 0.0080
CKMB on 
admission










− 0.2777 0.1023 − 0.0119 0.0044 − 2.7144 0.0081
Significant 
Cx stenosis
0.2148 0.0948 0.1747 0,0771 2.2654 0.0261
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who underwent complete coronary revascularisation in the 
acute phase of STEMI have a better prognosis than the oth-
ers [16, 17]. These studies raise controversies, mainly due 
to the fact that the results are inconsistent with the results 
of large trials and meta-analyses [18–21]. Newly presented 
and vastly discussed trials seem to only support the justifica-
tion of complete revascularisation in patients with myocar-
dial infarction regarding the aspect of the improvement of 
the prognosis. However, they do not report the optimal time 
of complete revascularisation. Undoubtedly, we will be pro-
vided with more information from large randomised ongo-
ing trials, e.g. the COMPLETE study. In the presented study, 
staged revascularisation was performed during a period of 1 
month in all the subjects. Consequently, it should not affect 
the differences in mortality between the groups. Regardless 
of such treatment, the prognosis of patients with Cx stenosis 
was worse. Poor outcomes of the Cx group of patients may 
finally result from missing ECG changes at the time of Cx 
reocclusion during the observation. This suggests that the 
12-lead ECG alone is often not enough for the diagnosis of 
patients with suspected Cx occlusion or narrowing. Accord-
ing to the authors, this may stem from the fact that electro-
cardiographically asymptomatic Cx reocclusion during the 
follow-up could be more common than in the case of RCA. 
The issue refers to long-term follow-up and not only to the 
anterior infarction-related period. This may result from ath-
erosclerosis progression, acceleration of the narrowing in 
already diseased vessels and finally myocardial ischaemia. 
Additionally, it may be caused by acute occlusion related to 
the atherosclerotic plaque rupture in that artery. However, 
these are only unconfirmed assumptions. Therefore, we 
should be aware of features of Cx occlusion other than ST-
segment elevation, such as isolated ST-segment depression 
in precordial leads (the greatest in leads V2 and V3) [22]. 
According to our findings, patients with anterior STEMI 
and Cx stenosis represent a group that requires a thorough 
evaluation during the follow-up period. Cx is a coronary 
artery requiring special attention because its stenosis in 
patients with anterior STEMI treated with PCI of the LAD 
leads to a worse prognosis in comparison with patients with 
RCA narrowing.
This study has a few limitations. First is the relatively 
small number of patients. However, to achieve a homoge-
nous group of patients, we studied 3121 consecutive patients 
with STEMI. The observed correlation could be confirmed 
in the future with prospective and larger population studies. 
Moreover, we used overall mortality as an endpoint, due to 
the fact that it was not possible to define the cause of death 
in all cases. Thus, we are not certain whether all reported 
deaths were cardiovascular. Concluding, significant narrow-
ing of the Cx leads to worse outcomes than narrowing of 
the RCA in patients with STEMI treated with PCI of the 
LAD. Thus, patients with Cx narrowing should be treated 
nosis on the mortality are equivocal [12, 13]. Nevertheless, 
it seems that the presence of coronary heart disease itself 
and its advancement are more important in the prognosis 
than the appearance of restenosis, which can be effectively 
treated today [13]. We did not evaluate the influence of the 
type of stent on mortality in our study. However, there were 
no differences concerning the prevalence of DES in the 
compared groups (Table 1).
It should be borne in mind that disease affecting different 
segments and arteries may lead to diverse outcomes. The 
location of a lesion in the LAD could be of key importance in 
the prognosis of patients with STEMI, due to the fact that the 
occlusion of the proximal LAD is related to more extensive 
heart muscle damage and therefore worse outcomes [10]. 
Nevertheless, the location of LAD occlusion did not present 
with differences in our analysis, which is also reflected in 
the lack of differentiation of the ejection fraction of the left 
ventricle, a direct exponent of the level of impairment of left 
ventricle. The Cx artery is the least frequent culprit vessel 
among patients treated invasively for STEMI [3]. Further-
more, patients with Cx occlusion are less likely to present 
ST-segment elevation, hence they remain underdiagnosed. 
Nevertheless, it has not been established if the outcome dif-
fers depending on whether the stenosis is in the Cx or RCA, 
in patients with anterior STEMI treated invasively. In the 
presented study, we found that patients with Cx narrow-
ing present with worse outcomes. The explanation for such 
an observation has not been clearly defined. Patients with 
LAD narrowing usually have collateral circulation from the 
RCA artery. Thus, RCA narrowing in patients with ante-
rior STEMI should lead to worse compensatory backflow 
to the occluded LAD, affecting the outcome more than Cx 
stenosis. Moreover, some studies suggested that Cx-related 
STEMI is usually smaller compared with RCA-related 
STEMI [14]. Such an observation should not be referred to 
the general population of patients with STEMI until coro-
nary artery dominance is taken into consideration. Veltman 
et al. [15] reported that the prognosis of STEMI patients dur-
ing a 30-day follow-up is worse in the case of left coronary 
artery dominance. According to the cited observation, dis-
crepancies in the prognosis may result from the dominance 
of one artery and not directly from the type of the artery—
Cx or RCA. In the presented study, the prevalence of right 
dominance was similar in the two groups, hence it may not 
constitute an explanation for the differences in mortality. On 
the other hand, the differences in mortality may stem from 
the fact that Cx stenosis in patients with anterior STEMI can 
be interpreted as an equivalent of left main disease, leading 
to worse outcome. Nevertheless, all the patients in our study 
underwent staged PCI procedures and were fully revascu-
larised. This is of key importance taking into consideration 
the debate on the justification of complete revascularisation 
in STEMI. The latest publications have shown that patients 
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more cautiously and require special attention after anterior 
STEMI treated with PCI of LAD.
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